BMC Ophthalmology

Section Editors

Andrew Dick, University of Bristol
Paul Foster, UCL Institute of Ophthalmology
Irene Gottlob, University Hospitals of Leicester, Leicester University
Hemant Khanna, University of Massachusetts Medical School
Namrata Sharma, Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS

Executive Editor

Emilie Aime, BioMed Central

Editorial Board | Editorial Team | Instructions for authors | FAQ

Articles

There has been an error retrieving the data. Please try again.

Inflamatory eye disease in translation

Associate Editor Alastair Denniston and Section Editor Andrew Dick review past remedies, current treatments what the future might hold for inflammatory eye disease research in translation.

BMC Ophthalmology 2013, 13:18
Cystatin role in ocular inflammation?

Human cystatin C is more highly expressed and in a wider range of cells in the conjunctiva of people with pterygium (a fibrovascular lesion of the ocular surface), suggesting it may have a role in inflammatory ocular conditions.

BMC Ophthalmology 2013, 13:6
Steroids may save rejected corneal grafts

Corneal grafts which are severely rejected following penetrating keratoplasty can have their transparency saved in approximately two thirds of cases by the use of topical and systemic steroids, with earlier treatment being beneficial.

BMC Ophthalmology 2013, 13:5
Glaucoma impacts driving habits

Older people with glaucoma and visual field loss associated with glaucoma are more likely to stop or limit their driving, although whether this is sufficient to ensure safety without impacting quality of life remains to be established.

BMC Ophthalmology 2013, 13:4
View more articles

RSS

Comments

great report

Comment on: Lim et al. BMC Ophthalmology 2013, 13:3
Error in abstract

Comment on: Crossland et al. BMC Ophthalmology 2011, 11:5
Typographical error

Comment on: Thapa et al. BMC Ophthalmology 2011, 11:2

Hot topic

Unilateral proptosis in thyroid eye disease with subsequent contralateral involvement: retrospective follow-up study

Strianese D, Piscopo R, Elefante A, Napoli M, Comune C, Baronissi I, Liuzzi R, Ferrara M et al.

BMC Ophthalmology 2013, 13:21

RSS

News from the web

16 June 2013: Engineered Virus Will Improve Gene Therapy For Blinding Eye Diseases

16 June 2013: Eyeball Licking (Oculolinctus) Can Be Dangerous, Doctors Warn

16 June 2013: New Layer In Human Eye Discovered

Scope

BMC Ophthalmology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of eye disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

Join the Editorial Board!

Are you interested in becoming an Editorial Board member for BMC Ophthalmology and helping to maintain the editorial standards and ethos of this growing journal? To volunteer as an Associate Editor, please simply contact us at bmcophthalmol@biomedcentral.com, enclosing a summary of your research interests and relevant expertise. We look forward to hearing from you.

Endorsing quality peer review

BMC Ophthalmology is dedicated to high quality peer review and endorses a free of charge, online peer review course entitled Translating Critical Appraisal of a Manuscript into Meaningful Peer Review, which is run by the Cochrane Eyes and Vision Group. The course aims to serve as a resource for health professionals, particularly ophthalmologists, optometrists, and other vision practitioners, who are serving or wish to serve as peer reviewers of the biomedical literature. To enrol on the course or for more information please see their website.

RSS